SportsMed Physical Therapy, a leading provider of outpatient rehabilitation and wellness services, proudly announces the opening of a brand-new clinic in Riverdale, New Jersey. This expansion brings ...

Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data and AI, presented NeuLogiq® ...

Some early signs of ALS may include muscle cramps in the arm, leg, shoulder or tongue, trouble walking, tripping and falling, weakness in the legs, arm or neck, slurred and nasal speech ...

Trace is partnering with Unlearn as it advances plans for a clinical trial of its treatment candidate that targets the UNC13A ...

For the millions of people worldwide who have lost their ability to speak due to stroke, ALS, or other neurological injuries, ...

The research team overcame the issue of latency – the delay between a person's intent to speak and the production of sound – ...

The 'mind-reading' interface now mimics natural language instead of sounding like a piece of outdated text-to-speech software ...

An FDA advisory committee has voted by a huge margin that BrainStorm’s stem cell therapy for ... of the data. Treatment with NurOwn involves harvesting stem cells from ALS patients’ bone ...

Edaravone, an approved amyotrophic lateral sclerosis (ALS ... than 1,000 genes as early as six hours after treatment, a response not seen with vitamin C. Looking more closely, the researchers found ...

The approval makes Relyvrio (sodium phenylbutyrate and taurursodiol) the first new therapy option for ALS – also known as motor neuron disease (MND) – since Mitsubishi Tanabe Pharma's ...